Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rogier W Sanders

Showing results (161-170 of 326) with videos related to

Pageof 33
Sort By:
European Journal of Immunology|January 31, 2022
SARS-CoV-2 infection activates dendritic cells via cytosolic receptors rather than extracellular TLRsLieve E H van der Donk, Julia Eder, John L van Hamme, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2013
Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9Jean-Philippe Julien, Jeong Hyun Lee, Albert Cupo, et al.
Plos Pathogens|March 7, 2022
Distinct spatial arrangements of ACE2 and TMPRSS2 expression in Syrian hamster lung lobes dictates SARS-CoV-2 infection patternsIlhan Tomris, Kim M Bouwman, Youri Adolfs, et al.
Journal of Pharmaceutical Sciences|February 19, 2019
Developability Assessment of Physicochemical Properties and Stability Profiles of HIV-1 BG505 SOSIP.664 and BG505 SOSIP.v4.1-GT1.1 gp140 Envelope Glycoprotein Trimers as Candidate Vaccine AntigensNeal Whitaker, John M Hickey, Kawaljit Kaur, et al.
Virology|March 23, 2010
Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry functionDirk Eggink, Mark Melchers, Manfred Wuhrer, et al.
Cell Reports|September 7, 2024
Defining bottlenecks and opportunities for Lassa virus neutralization by structural profiling of vaccine-induced polyclonal antibody responsesPhilip J M Brouwer, Hailee R Perrett, Tim Beaumont, et al.
Plos Pathogens|August 15, 2024
Primary SARS-CoV-2 variant of concern infections elicit broad antibody Fc-mediated effector functions and memory B cell responsesKarlijn van der Straten, Denise Guerra, Gius Kerster, et al.
Journal of Proteome Research|February 9, 2018
Integrity of Glycosylation Processing of a Glycan-Depleted Trimeric HIV-1 Immunogen Targeting Key B-Cell LineagesAnna-Janina Behrens, Abhinav Kumar, Max Medina-Ramirez, et al.
Journal of Virology|October 30, 2015
Chemical Cross-Linking Stabilizes Native-Like HIV-1 Envelope Glycoprotein Trimer AntigensTorben Schiffner, Natalia de Val, Rebecca A Russell, et al.
Biorxiv : the Preprint Server for Biology|August 15, 2020
Cross-neutralization of a SARS-CoV-2 antibody to a functionally conserved site is mediated by avidityHejun Liu, Nicholas C Wu, Meng Yuan, et al.
Pageof 33

Showing results (161-170 of 326) with videos related to

Sort By:
Pageof 33
European Journal of Immunology|January 31, 2022
SARS-CoV-2 infection activates dendritic cells via cytosolic receptors rather than extracellular TLRsLieve E H van der Donk, Julia Eder, John L van Hamme, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2013
Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9Jean-Philippe Julien, Jeong Hyun Lee, Albert Cupo, et al.
Plos Pathogens|March 7, 2022
Distinct spatial arrangements of ACE2 and TMPRSS2 expression in Syrian hamster lung lobes dictates SARS-CoV-2 infection patternsIlhan Tomris, Kim M Bouwman, Youri Adolfs, et al.
Journal of Pharmaceutical Sciences|February 19, 2019
Developability Assessment of Physicochemical Properties and Stability Profiles of HIV-1 BG505 SOSIP.664 and BG505 SOSIP.v4.1-GT1.1 gp140 Envelope Glycoprotein Trimers as Candidate Vaccine AntigensNeal Whitaker, John M Hickey, Kawaljit Kaur, et al.
Virology|March 23, 2010
Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry functionDirk Eggink, Mark Melchers, Manfred Wuhrer, et al.
Cell Reports|September 7, 2024
Defining bottlenecks and opportunities for Lassa virus neutralization by structural profiling of vaccine-induced polyclonal antibody responsesPhilip J M Brouwer, Hailee R Perrett, Tim Beaumont, et al.
Plos Pathogens|August 15, 2024
Primary SARS-CoV-2 variant of concern infections elicit broad antibody Fc-mediated effector functions and memory B cell responsesKarlijn van der Straten, Denise Guerra, Gius Kerster, et al.
Journal of Proteome Research|February 9, 2018
Integrity of Glycosylation Processing of a Glycan-Depleted Trimeric HIV-1 Immunogen Targeting Key B-Cell LineagesAnna-Janina Behrens, Abhinav Kumar, Max Medina-Ramirez, et al.
Journal of Virology|October 30, 2015
Chemical Cross-Linking Stabilizes Native-Like HIV-1 Envelope Glycoprotein Trimer AntigensTorben Schiffner, Natalia de Val, Rebecca A Russell, et al.
Biorxiv : the Preprint Server for Biology|August 15, 2020
Cross-neutralization of a SARS-CoV-2 antibody to a functionally conserved site is mediated by avidityHejun Liu, Nicholas C Wu, Meng Yuan, et al.
Pageof 33